ArticleImmunology2026

Long-Acting Cabotegravir/Rilpivirine Reduces Immune-Activation and -Senescence in People With HIV With CMV Co-Infection.

Mariasilvia Guardiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.